Research ArticleClinical Investigations
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, Otto S. Hoekstra, Egbert F. Smit, Adrianus Johannes de Langen and Ronald Boellaard
Journal of Nuclear Medicine September 2016, 57 (9) 1343-1349; DOI: https://doi.org/10.2967/jnumed.115.170225
Gerbrand Maria Kramer
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Virginie Frings
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Nikie Hoetjes
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Otto S. Hoekstra
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands
Egbert F. Smit
2Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands; and
3Department of Thoracic Oncology, Netherlands cancer Institute, Amsterdam, The Netherlands
Adrianus Johannes de Langen
2Department of Pulmonology, VU University Medical Center, Amsterdam, The Netherlands; and
Ronald Boellaard
1Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 9
September 1, 2016
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, Otto S. Hoekstra, Egbert F. Smit, Adrianus Johannes de Langen, Ronald Boellaard
Journal of Nuclear Medicine Sep 2016, 57 (9) 1343-1349; DOI: 10.2967/jnumed.115.170225
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, Otto S. Hoekstra, Egbert F. Smit, Adrianus Johannes de Langen, Ronald Boellaard
Journal of Nuclear Medicine Sep 2016, 57 (9) 1343-1349; DOI: 10.2967/jnumed.115.170225
Jump to section
Related Articles
Cited By...
- Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
- Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer 18F-FDG PET Radiomics
- Repeatability of 68Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume
- Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
- Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer
- Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer
- Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network
- The Influence of Minimal Misalignment on the Repeatability of PET Images Examined by the Repositioning of Point Sources
- 18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non-Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
- Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials
- Reply: Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures in Patients with Non-Small Cell Lung Cancer: Dynamic Versus Test-Retest Design
- Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures in Patients with Non-Small Cell Lung Cancer: Dynamic Versus Test-Retest Design
- Need for Glucose Correction for 18F-FDG PET Influenced by Glucose Sensitivities to Types of Tissue and Random Factors
- Repeatability of SUV in Oncologic 18F-FDG PET